NDC 42543-0407-01
POTASSIUM CITRATE 10 meq/1 TABLET
Available — 2-Day Shipping
NDC
42543-0407-01
Generic Name
POTASSIUM CITRATE
Brand Name
POTASSIUM CITRATE EXTENDED RELEASE
Strength
10 meq/1
Dosage Form
TABLET
Route
ORAL
Package Size
—
Labeler
Strides Pharma Inc.
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Potassium citrate is a citrate salt of potassium indicated for the management of: • Renal tubular acidosis (RTA) with calcium stones (1.1) • Hypocitraturic calcium oxalate nephrolithiasis of any etiology (1.2) • Uric acid lithiasis with or without calcium stones (1.3) 1.1 Renal Tubular Acidosis (RTA) with Calcium Stones Potassium citrate is indicated for the management of renal tubular acidosis [see Clinical Studies (14.1)] . 1.2 Hypocitraturic Calcium Oxalate Nephrolithi…
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All POTASSIUM CITRATE Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Other POTASSIUM CITRATE NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 42543-0407-01 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).